Today News Journal
    What's Hot

    Trump Isn’t Touting His Biggest Success

    February 5, 2023

    The Colorado River Is Disappearing. Here’s How to Replenish It.

    February 5, 2023

    Fake Meat’s Beyond Impossible Quest to Win Over Americans

    February 5, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram
    Today News Journal
    Contact Us
    • Home
    • Trending
    • Business
    • Health
    • Technology
      • Automobile
      • Gadgets
      • Mobiles
      • Robotics
    • Lifestyle
      • Culture
    • Sports
    • Travel
    • Editorials
    • News
      • Politics
    Today News Journal
    Home » Business » Biocheck Inc Acquires Drg International Inc, A Leading Ivd Company
    Business

    Biocheck Inc Acquires Drg International Inc, A Leading Ivd Company

    James MartinBy James MartinAugust 18, 2021Updated:August 19, 2021No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms
    BioCheck, Inc. ( https://c212.net/c/link/?t=0&l=en&o=3263650-1&h=2004886458&u=https%3A%2F%2Fcts.businesswire.com%2Fct%2FCT%3Fid%3Dsmartlink%26url%3Dhttp%253A%252F%252Fwww.perkinelmer.com%26esheet%3D52465436%26newsitemid%3D20210726005241%26lan%3Den-US%26anchor%3DPerkinElmer%252C%2BInc.%26index%3D1%26md5%3D5c6d80a1d3faf6cb9cbd2ea6178a928d&a=BioCheck%2C+Inc. ) has announced that it has acquired DRG International, a leading manufacturer of clinical diagnostic and research ELISAs with distributors in over 110 countries.  DRG is also the manufacturer of the DRG:HYBRiD-XL(R), a fully automated analyzer for Immunoassays and Clinical Chemistry.  DRG International, Inc. operates in accordance with the FDA 21 CFR 820 Quality System Regulation as well as the ISO 13485:2016 and MDSAP (Medical Device Single Audit Program) by TÜV Rheinland.

    Roy Paxton Yih, CEO of BioCheck, Inc. said ” the DRG:HYBRiD-XL(R) and BioCheck’s new automated chemiluminescent platform (ACL-Platform) will enable us to accelerate the availability of optimized, reliable and accurate advanced clinical and research diagnostic tests in the neurological  disorders and other diseases.  Leveraging BioCheck’s assay development capabilities with DRG’s development center, the combined companies are well positioned to rapidly scale availability of current tests and develop novel IVD tests for several diseases in the future globally to over 110 countries.”

    Global IVD Diagnostic Market news provided by “Research and Markets Publication” June 8, 2021

    “At an estimated value of over USD 72.02 billion in 2019, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a CAGR of 4.1%  and valued at over USD 112.05 billion over the forecast year 2020-2030.

    “In vitro diagnostics is experiencing a significant popularity in healthcare sector due to its efficacy in diagnosing numerous medical conditions such as infectious diseases, cardiac disorders, cancer, and  nephrological disorders.

    Upsurge in number of in vitro diagnostic tests across the globe owing to the increased incidences of infectious and chronic diseases drives the growth of IVD market. In addition, rise in geriatric population,
    which is vulnerable to immunological disorders have been pushing the growth of the market globally.”

    Yih also added “We look forward to welcoming the highly talented members of the DRG team who bring additional R&D capabilities and manufacturing strength to BioCheck, helping to further elevate our clinical and research IVD business.”

    About BioCheck, Inc.

    Since 1997, BioCheck, Inc. has been engaged in the development and manufacturing of high-quality in vitro diagnostic test kits for the worldwide biomedical, pharmaceutical, and scientific research markets under cGMP and ISO 13485 standards.  BioCheck is commercializing the (automated chemiluminescent platform (ACL-Platform)) and associated Covid-19 and other cytokine, metabolic, and cardiovascular test kits to allow convenient, instant, and accurate diagnosis of disease markers with a bench top instrument.  BioCheck is financed by seasoned biotech investors Emerging Technology Partners.  www.biocheckinc.com

    SOURCE: BioCheck Inc

    CONTACT: info@biocheckinc.com

    Related posts:

    1. BitMEX Confirms It Has Reached Settlements With CFTC And FinCEN
    2. Chateau Quintus Grows With The Acquisition Of Chateau Grand-Pontet
    3. Binance Recruits First Chief Communications Officer As It Continues Evolution Into A Global Financial Institution
    4. PR Newswire’s Business & Finance Media Pitching Kit 2021 (APAC Edition) Shares News and Trends on the Radar of Journalists
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleHenley & Partners Submits 100th Application For Montenegro Citizenship-By-Investment Program
    Next Article GD1’s Fund 3 First Close Raises $130m For Nz’s Most Abitious And Globally Minded Startups More Than Double Its Original First Close Target
    James Martin
    • Website

    Related Posts

    Is Loughton A Good Choice For Raising A Family?

    January 31, 2023

    A Brief Introduction To Local SEO Citation

    April 28, 2022

    Tips To Hire Blogger Outreach Companies In The UK

    April 25, 2022

    Everything You Need To Know About Niche Edits

    April 22, 2022

    Leave A Reply Cancel Reply

    Search
    Categories
    • Automobile
    • Business
    • Coronavirus
    • Culture
    • Editorials
    • Finance
    • Gadgets
    • Health
    • Lifestyle
    • Mobiles
    • Money
    • News
    • Politics
    • Sports
    • Technology
    • Travel
    • Trending
    • World
    Latest Posts

    Trump Isn’t Touting His Biggest Success

    February 5, 2023

    The Colorado River Is Disappearing. Here’s How to Replenish It.

    February 5, 2023

    Fake Meat’s Beyond Impossible Quest to Win Over Americans

    February 5, 2023

    Here’s How Finland, Sweden and NATO Should Deal With Erdogan

    February 5, 2023
    • Facebook
    • Twitter
    Don't Miss
    News

    Trump Isn’t Touting His Biggest Success

    By James MartinFebruary 5, 20230

    Comment on this storyCommentOne sunny spring morning in May 2020, President Donald Trump stood in…

    The Colorado River Is Disappearing. Here’s How to Replenish It.

    February 5, 2023

    Fake Meat’s Beyond Impossible Quest to Win Over Americans

    February 5, 2023

    Here’s How Finland, Sweden and NATO Should Deal With Erdogan

    February 5, 2023
    • Facebook
    • Twitter
    About Us

    Hello friends, I am James Martin. Welcome to my blog todaynewsjournal.com. We are a team of experienced journalists who are passionate about delivering the latest news and current events to our readers. Our editorial team is dedicated to providing the most accurate and up-to-date information possible. We aim to be your go-to source for news and current events. Here on this site, You will get up to date information regarding all important categories like business ideas, health tips,... (Read More)

    Latest News

    Trump Isn’t Touting His Biggest Success

    February 5, 2023

    The Colorado River Is Disappearing. Here’s How to Replenish It.

    February 5, 2023

    Fake Meat’s Beyond Impossible Quest to Win Over Americans

    February 5, 2023
    SIGN UP NEWSLETTER

    Join The Conversation sign up to receive emails for The Daily special tips general info.

      Facebook Twitter Instagram Pinterest
      • Home
      • Editorials
      • Get In Touch

      Copyright © 2021-2023 · Today News Journal Privacy Policy

      Type above and press Enter to search. Press Esc to cancel.

      We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
      Cookie SettingsAccept All
      Manage consent

      Privacy Overview

      This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
      Necessary
      Always Enabled
      Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
      CookieDurationDescription
      cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
      cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
      cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
      cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
      cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
      viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
      Functional
      Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
      Performance
      Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
      Analytics
      Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
      Advertisement
      Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
      Others
      Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
      SAVE & ACCEPT

      Sign In or Register

      Welcome Back!

      Login to your account below.

      Lost password?